BIO LOGIC SYSTEMS CORP
S-8, 1997-09-17
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: SECURITY TAX EXEMPT FUND, N-30D, 1997-09-17
Next: PRICE COMMUNICATIONS CORP, SC 14D1/A, 1997-09-17



<PAGE>

   As filed with the Securities and Exchange Commission on September 17, 1997

                              Registration No. 333-

          -------------------------------------------------------------

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                 --------------

                                    FORM S-8
                             REGISTRATION STATEMENT

                                      UNDER
                           THE SECURITIES ACT OF 1933

                             Bio-Logic Systems Corp.
               ----------------------------------------------------
             (Exact name of registrant as specified in its charter)

                                    Delaware
               ----------------------------------------------------
         (State or other jurisdiction of incorporation or organization)

                                   36-3025678
               ----------------------------------------------------
                      (I.R.S. employer identification no.)

                  One Bio-Logic Plaza, Mundelein, IL 60060-3700
               ----------------------------------------------------
                    (Address of principal executive offices)

                             1994 Stock Option Plan
                         -------------------------------
                              (Full title of plan)

                            Gabriel Raviv, President
                            Bio-Logic Systems, Corp.
                               One Bio-Logic Plaza
                            Mundelein, IL 60060-3700
                 ----------------------------------------------
                     (Name and address of agent for service)

                                 (847) 949-5200
          -------------------------------------------------------------
          (Telephone number, including area code, of agent for service)

                                    Copy to:
                               Jill M. Cohen, Esq.
                      Bachner, Tally, Polevoy & Misher LLP
                               380 Madison Avenue
                               New York, NY 10017

<PAGE>

===============================================================================
                        CALCULATION OF REGISTRATION FEE
===============================================================================
                                Proposed    Proposed   
                                Maximum     Maximum    
                                Offering    Aggregate              Amount of 
     Title of Securities          to be     Price Per  Offering   Registration
       to be Registered        Registered   Share(2)    Price         Fee    
===============================================================================
Common Stock $.01 par value    400,000(1)     $5.47    $2,188,000  $663.00(3)
===============================================================================

(1)   Pursuant to Rule 416, promulgated under the Securities Act of 1933, as
      amended, an additional undeterminable number of shares of Common Stock is
      being registered to cover any adjustment in the number of shares of Common
      Stock pursuant to the anti-dilution provisions of the 1994 Stock Option
      Plan, as amended.

(2)   Estimated in accordance with Rule 457(h) solely for the purpose of
      calculating the registration fee. The price shown is the average of the
      high and low prices of the Common Stock on September 12, 1997 as reported
      on Nasdaq.

(3)   A payment of  $538.00 is being made herewith, as $125.00 has previously 
      been paid.

                                      -2-
<PAGE>

                                    PART II

              INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.     INCORPORATION OF DOCUMENTS BY REFERENCE

                  The Registration Statement on Form S-8 (File No. 33-62237),
filed by BIO-LOGIC SYSTEMS CORP. (the "Registrant") on August 30, 1995, and the
documents listed below are hereby incorporated by reference into this
Registration Statement, and all documents subsequently filed by the Registrant
pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act
of 1934, as amended, prior to the filing of a post-effective amendment which
indicates that all securities offered have been sold or which deregisters all
securities then remaining unsold, shall be deemed to be incorporated by
reference in this Registration Statement and to be part hereof from the date of
filing such documents:

            (a)   The Registrant's Annual Report on Form 10K-SB 
            (File No. 0-12231) for its fiscal year ending February 28, 1997.

            (b)   The Registrant's quarterly report on Form 10Q-SB for the 
            quarterly period ended May 31, 1997; and

            (c) The Registrant's Registration Statement on Form 8-A, as filed
            with the Securities and Exchange Commission on June 6, 1994 to 
            register the Common Stock, $.01 par value, under Section 12(g) of 
            the Securities and Exchange Act of 1934, as amended.

Item 8.     EXHIBITS

            5     Opinion of Bachner, Tally, Polevoy & Misher LLP, with respect 
                  to the legality of the
                  Common Stock to be registered hereunder

            10.15 1994 Stock Option Plan, as amended

            24(a) Independent Audit's Consent

            24(b) Consent of Bachner, Tally, Polevoy & Misher LLP
                  (contained in Exhibit 5)

                                      -3-
<PAGE>

Item 9.     UNDERTAKINGS

            (a)   The undersigned Registrant hereby undertakes:

                  (1) To file, during any period in which offers or sales are
            being made a post-effective amendment to this Registration
            Statement;

                        (i)   To include any prospectus required by 
                  Section 10(a)(3) of the Securities Act of 1933;

                        (ii) To reflect in the prospectus any facts or events
                  arising after the effective date of the Registration Statement
                  (or the most recent post-effective amendment thereof) which,
                  individually or in the aggregate, represent a fundamental
                  changed in the information set forth in the Registration
                  Statement. Notwithstanding the foregoing, any increase or
                  decrease in volume of securities offered (if the total dollar
                  value of securities offered would not exceed that which was
                  registered) and any deviation from the low or high end of the
                  estimated maximum offering range may be reflected in the form
                  of prospectus filed with the Commission pursuant to Rule
                  424(b) if, in the aggregate, the changes in volume and 
                  price represent no more than 20 percent change in the maximum
                  aggregate offering price set forth in the "Calculation of
                  Registration Fee" table in the effective registration
                  statement.

                        (iii) To include any material information with respect
                  to the plan of distribution not previously disclosed in the
                  Registration Statement or any material change to such
                  information in the Registration Statement;

                        Provided, however, that paragraphs (a)(1)(i) and
                  (a)(1)(ii) do not apply if the registration statement is on
                  Form S-3 or Form S-8, and the information required to be
                  included in a post-effective amendment by those paragraphs is
                  contained in periodic reports filed by the Registrant pursuant
                  to Section 13 or Section 15(d) of the Securities Exchange Act
                  of 1934 that are incorporated by reference in the registration
                  statement.

                  (2) That, for the purpose of determining any liability under
            the Securities Act of 1933, each such post-effective amendment shall
            be deemed to be a new registration statement relating to the
            securities offered therein, and the offering of such securities at
            that time shall be deemed to be the initial bona fide offering
            thereof.

                  (3) To remove from the registration by means of post-effective
            amendment any of the securities being registered which remain unsold
            at the termination of the offering.

            (b) The undersigned Registrant hereby undertakes that, for purposes
      of determining any liability under the Securities Act of 1933, each filing
      of the Registrant's annual report pursuant to Section 13(a) or Section
      15(d) of the Securities Exchange Act of 1934 (and, where applicable, each

                                      -4-
<PAGE>

      filing of an employee benefit plan's annual report pursuant to Section
      15(d) of the Securities Exchange Act of 1934) that is incorporated by
      reference in the registration statement shall be deemed to be a new
      registration statement relating to the securities offered therein, and the
      offering of such securities at that time shall be deemed to be the initial
      bona fide offering thereof.

            (h) Insofar as indemnification for liabilities arising under the
      Securities Act of 1933 may be permitted to directors, officers and
      controlling persons of the Registrant pursuant to the foregoing
      provisions, or otherwise, the Registrant has been advised that, in the
      opinion of the Securities and Exchange Commission, such indemnification is
      against public policy as expressed in the Act and is, therefore,
      unenforceable. In the event that a claim for indemnification against such
      liabilities (other than the payment by the Registrant of expenses incurred
      or paid by a director, officer or controlling person of the Registrant in
      the successful defense of any action, suit or proceeding) is asserted by
      such director, officer or controlling person in connection with the
      securities being registered, the Registrant will, unless in the opinion of
      its counsel the matter has been settled by controlling precedent, submit
      to a court of appropriate jurisdiction the question whether such
      indemnification by it is against public policy as expressed in the Act and
      will be governed by the final adjudication of such issue.

                                      -5-
<PAGE>

                                  SIGNATURES

      Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in city of Chicago, State of Illinois, on the 15th day of September,
1997.

                                    BIO-LOGIC SYSTEMS CORP.


                                    By: /S/ GABRIEL RAVIV
                                       -------------------------- 
                                        President and Chief Executive Officer

      Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed below by the following persons in the
capacities and as of the date indicated.

<TABLE>
<CAPTION>

             SIGNATURE                    TITLE                     DATE

<S>                                <C>                           <C>

  /S/ GABRIEL RAVIV              President, Chief Executive     September 15, 1997
- -------------------------------  Officer and Director                             
Gabriel Raviv                    (Principle Executive Officer)                    


 /S/ WILLIAM K. ROENITZ          Controller                     September 15, 1997
- -------------------------------  (Principal Accounting Officer)                  
William K. Roenitz               

                                 
 /S/ GIL RAVIV                   Director                       September 15, 1997
- -------------------------------
Gil Raviv


 /S/ CHARLES Z. WEINGARTEN, M.D. Director                       September 15, 1997
- --------------------------------
Charles Z. Weingarten, M.D.


 /S/ IRVING KUPFERBERG           Director                       September 15, 1997
- --------------------------------
Irving Kupferberg


 /S/ ALBERT MILSTEIN             Director                       September 15, 1997
- --------------------------------
Albert Milstein


 /S/ CRAIG W. MOORE              Director                       September 15, 1997
- --------------------------------
Craig W. Moore

</TABLE>

<PAGE>

                               INDEX TO EXHIBITS
                            BIO-LOGIC SYSTEMS CORP.

Exhibit
  NO.                             DESCRIPTION

   5              Opinion of Bachner, Tally, Polevoy & Misher LLP,
                  with respect to the legality of the Common Stock
                  to be registered hereunder

 10.15            1994 Stock Option Plan, as amended

 24(a)            Independent Auditor's Consent

 24(b)            Consent of Bachner, Tally, Polevoy & Misher LLP
                        (contained in Exhibit 5)


<PAGE>

                                   EXHIBIT 5

<PAGE>

                                                September 16, 1997

Bio-logic Systems Corp.
One Bio-logic Plaza
Mundelein, Illinois  60060-3700

            Re:   REGISTRATION STATEMENT ON FORM S-8

Gentlemen:

            We have served as your counsel in connection with the preparation of
your Registration Statement on Form S-8 to be filed with the Securities and
Exchange Commission under the Securities Act of 1933, as amended, representing
the offering and issuance to certain persons under the 1994 Stock Option Plan,
as amended (the "Plan") of an aggregate of 850,000 shares of your Common Stock,
$.01 par value (the "Common Stock").

            We have examined such corporate records, documents and matters of
law as we have considered appropriate for the purposes of this opinion.

            Based upon such examination and our participation in the preparation
of the Registration Statement, is it our opinion that the Common Stock, when
issued in the manner described in the Plan will be validly issued, fully paid
and non-assessable.

            We consent to the reference made to our firm in the Registration
Statement and to the filing of this opinion as an exhibit to the Registration
Statement.

                                     Very truly yours,

                                     /s/ Bachner, Tally, Polevoy & Misher LLP
                                   ------------------------------------------
                                   BACHNER, TALLY, POLEVOY & MISHER LLP


<PAGE>

                                  EXHIBIT 10.15

<PAGE>


                             BIO-LOGIC SYSTEMS CORP.

                            1994 STOCK OPTION PLAN,
                                  AS AMENDED

1.          PURPOSE.

            The purpose of this plan (the "Plan") is to secure for Bio-Logic
Systems Corp. (the "Company") and its stockholders the benefits arising from
capital stock ownership by employees, officers and directors of, and consultants
or advisors to, the company and its subsidiary corporations who are expected to
contribute to the company's future growth and success. Except where the context
otherwise requires, the term "Company" shall include all present and future
subsidiaries of the Company as defined in sections 424(e) and 424(f) of the
Internal Revenue Code of 1986, as amended or replaced from time to time (the
"Code"). Those provisions of the Plan which make express reference to section
422 shall apply only to incentive stock options (as that term is defined in the
Plan).

2.          TYPE OF OPTIONS AND ADMINISTRATION.

            (A) TYPES OF OPTIONS. Options granted pursuant to the Plan shall be
authorized by action of the board of directors of the Company (or a committee
designated by the board of directors) and may be either incentive stock options
("Incentive Stock Options") meeting the requirements of section 422 of the Code
or non-statutory options which are not intended to meet the requirements of
section 422 of the Code.

            (B) ADMINISTRATION. The plan will be administered by a committee
(the "Committee") appointed by the board of directors of the company, whose
construction and interpretation of the terms and provisions of the Plan shall be
final and conclusive. The delegation of powers to the committee shall be
consistent with applicable laws or regulations (including, without limitation,
applicable state law and rule 16b-3 promulgated under the Securities Exchange
Act of 1934 (the "Exchange Act"), or any successor rule ("Rule 16b-3")). The
Committee may in its sole discretion grant options to purchase shares of the
Company's Common Stock, $.01 par value per share ("Common Stock") and issue
shares upon exercise of such options as provided in the Plan. The Committee
shall have authority, subject to the express provisions of the Plan, to construe
the respective option agreements and the Plan, to prescribe, amend and rescind
rules and regulations relating to the Plan, to determine the terms and
provisions of the respective option agreements, which need not be identical, and
to make all other determinations in the judgment of the Committee necessary or
desirable for the administration of the Plan. The Committee may correct any
defect or supply any omission or reconcile any inconsistency in the Plan or in
any option agreement in the manner and to the extent it shall deem expedient to
carry the Plan into effect and it shall be the sole and final judge of such
expediency. No director or person acting pursuant to authority delegated by the
Board of 

<PAGE>

Directors shall be liable for any action or determination under the
Plan made in good faith. Subject to adjustment as provided in Section 15 below,
the aggregate number of shares of Common Stock that may be subject to options
granted to any person in a calendar year shall not exceed 100,000 shares of
Common Stock.

            (c) APPLICABILITY OF RULE 16B-3. Those provisions of the Plan which
make express reference to Rule 16b-3 shall apply to the Company only at such
time as the Company's Common Stock is registered under the Exchange Act, subject
to the last sentence of Section 3(b), and then only to such persons as are
required to file reports under Section 16(a) of the Exchange Act (a "Reporting
Person").

3.          ELIGIBILITY.

            (a) GENERAL. Options may be granted to persons who are, at the time
of grant, employees, officers or directors of, or consultants or advisors to,
the Company or any subsidiaries of the Company as defined in Section 424(e) and
424(f) of the Code ("Participants"); PROVIDED, that Incentive Stock Options may
only be granted to individuals who are employees of the Company (within the
meaning of Section 3401(c) of the Code). A person who has been granted an option
may, if he or she is otherwise eligible, be granted additional options if the
Committee shall so determine.

            (b) GRANT OF OPTIONS TO REPORTING PERSONS. The selection of a
director or an officer who is a Reporting Person (as the terms "director" and
"officer" are defined for purposes of Rule 16b-3) as a recipient of an option,
the timing of the option grant, the exercise price of the option and the number
of shares subject to the option shall be determined either (i) by the Board of
Directors, (ii) by a committee consisting of two or more directors having full
authority to act in the matter, each of whom shall be a "non-employee director"
or (iii) pursuant to provisions for automatic grants set forth in Section 3(c)
below. For the purposes of the Plan, a director shall be deemed to be a
"non-employee director" only if such person qualifies as a "non-employee
director" within the meaning of Rule 16b-3, as such term is interpreted from
time to time. If at least two of the members of the Board of Directors do not
qualify as a "non-employee director" within the meaning of Rule 16b-3, as such
term is interpreted from time to time, then the granting of options to officers
and directors who are Reporting Persons under the Plan shall not be determined
in accordance with this Section 3(b) but shall be determined in accordance with
the other provisions of the Plan.

            (c) DIRECTORS' OPTIONS. Commencing on the date this plan is adopted
by the Board of Directors, directors of the Company ("Eligible Directors") will
receive an option ("Director Option") to purchase 3,000 shares of Common Stock,
except for Craig W. Moore who will receive a Director Option to purchase 9,000
shares of Common Stock and Gabriel Raviv, Ph.D. who will receive a Director
Option to purchase 30,000 shares of Common Stock. Future Eligible Directors of
the Company will be granted a Director Option to purchase 3,000 shares of Common
Stock on the date that such person is first elected or appointed a director
("Initial 

<PAGE>

Director Option"). Commencing on the day immediately following the
date of the annual meeting of stockholders for the Company's fiscal year ending
February 28, 1995, each Eligible Director will receive an automatic grant
("Automatic Grant") of a Director Option to purchase 2,000 shares of Common
Stock, other than Eligible Directors who received an Initial Director Option
since the last Automatic Grant, on the day immediately following the date of
each annual meeting of stockholders, as long as such director is a member of the
Board of Directors. Director Options shall be Incentive Stock Options, if
permitted under the terms of this Plan and Section 422 of the Code, otherwise
they shall be non-statutory options. The exercise price for each share subject
to a Director Option shall be equal to the fair market value of the Common Stock
on the date of grant and such Director Options shall become exercisable in four
equal annual installments (except for 3,000 of the Director Options to be
granted to Craig W. Moore, which shall vest as follows: 750 shares on December
15, 1994; 750 shares on June 15, 1995; 750 shares on June 15, 1996; and 750
shares on June 15, 1997) and will expire the earlier of 10 years after the date
of grant or 90 days after the termination of the director's service on the
Board, unless such Director Option is an Incentive Stock Option in which case
such Director Options shall be subject to the additional terms and conditions
set forth in Section 11.

4.          STOCK SUBJECT TO PLAN.

            The stock subject to options granted under the Plan shall be shares
of authorized but unissued or reacquired Common Stock. Subject to adjustment as
provided in Section 15 below, the maximum number of shares of Common Stock of
the Company which may be issued and sold under the Plan is 850,000 shares. If an
option granted under the Plan shall expire, terminate or is cancelled for any
reason without having been exercised in full, the unpurchased shares subject to
such option shall again be available for subsequent option grants under the
Plan.

5.          FORMS OF OPTION AGREEMENTS.

            As a condition to the grant of an option under the Plan, each
recipient of an option shall execute an option agreement in such form not
inconsistent with the Plan as may be approved by the Board of Directors. Such
option agreements may differ among recipients.

6.          PURCHASE PRICE.

            (a) GENERAL. The purchase price per share of stock deliverable upon
the exercise of an option shall be determined by the Board of Directors at the
time of grant of such option; PROVIDED, however, that in the case of an
Incentive Stock Option, the exercise price shall not be less than 100% of the
Fair Market Value (as hereinafter defined) of such stock, at the time of grant
of such option, or less than 110% of such Fair Market Value in the case of
options described in Section 11(b). "Fair Market Value" of a share of Common
Stock of the Company as of a specified date for the purposes of the Plan shall
mean the closing price of a share of the Common Stock on the principal
securities exchange or other established trading market on which such shares are
traded on the day immediately preceding the date as of which Fair Market 

<PAGE>

Value is being determined, or on the next preceding date on which such shares
are traded if no shares were traded on such immediately preceding day. If the
shares are not publicly traded, Fair Market Value of a share of Common Stock
(including, in the case of any repurchase of shares, any distributions with
respect thereto which would be repurchased with the shares) shall be determined
in good faith by the Board of Directors. In no case shall Fair Market Value be
determined with regard to restrictions other than restrictions which, by their
terms, will never lapse.

            (b) PAYMENT OF PURCHASE PRICE. Options granted under the Plan may
provide for the payment of the exercise price by delivery of cash or a check to
the order of the Company in an amount equal to the exercise price of such
options, or, to the extent provided in the applicable option agreement, (i) by
delivery to the Company of shares of Common Stock of the Company having a Fair
Market Value on the date of exercise equal in amount to the exercise price of
the options being exercised, (ii) by any other means which the Board of
Directors determines are consistent with the purpose of the Plan and with
applicable laws and regulations (including, without limitation, the provisions
of Rule 16b-3 and Regulation T promulgated by the Federal Reserve Board) or
(iii) by any combination of such methods of payment.

7.          OPTION PERIOD.

            Subject to earlier termination as provided in the Plan, each option
and all rights thereunder shall expire on such date as determined by the Board
of Directors and set forth in the applicable option agreement, PROVIDED, that
such date shall not be later than (10) ten years after the date on which the
option is granted.

8.          EXERCISE OF OPTIONS.

            Each option granted under the Plan shall be exercisable either in
full or in installments at such time or times and during such period as shall be
set forth in the option agreement evidencing such option, subject to the
provisions of the Plan. No option granted to a Reporting Person for purposes of
the Exchange Act, however, shall be exercisable during the first six months
after the date of grant. Subject to the requirements in the immediately
preceding sentence, if an option is not at the time of grant immediately
exercisable, the Board of Directors may (i) in the agreement evidencing such
option, provide for the acceleration of the exercise date or dates of the
subject option upon the occurrence of specified events, and/or (ii) at any time
prior to the complete termination of an option, accelerate the exercise date or
dates of such option.

9.          NONTRANSFERABILITY OF OPTIONS.

            No incentive stock option granted under this Plan shall be
assignable or otherwise transferable by the optionee except by will or by the
laws of descent and distribution or pursuant to a qualified domestic relations
order as defined in the Code or Title I of the Employee Retirement Income
Security Act, or the rules thereunder. The Committee may, in its discretion,

<PAGE>

authorize all or a portion of any non-statutory options to be granted to an
optionee to be on terms which permit transfer by such optionee to (i) the
spouse, children or grandchildren of the optionee ("Immediate Family Members"),
(ii) a trust or trusts for the exclusive benefit of such Immediate Family
Members, or (iii) a partnership in which such Immediate Family Members are the
only partners, provided that (w) the options must be held by the optionee for a
period of at least one month prior to transfer, (x) there may be no
consideration for any such transfer, (y) the stock option agreement pursuant to
which such options are granted must be approved by the Committee, and must
expressly provide for transferability in a manner consistent with this Section,
and (z) subsequent transfers of transferred options shall be prohibited except
by will or the laws of descent and distribution or pursuant to a qualified
domestic relations order as defined in the Code or Title I of the Employee
Retirement Income Security Act, or the rules thereunder. Following transfer, any
such options shall continue to be subject to the same terms and conditions as
were applicable immediately prior to transfer, provided that for purposes of the
Plan the term "optionee" shall be deemed to refer to the transferee. The events
of termination of employment of Section 10 hereof shall continue to be applied
with respect to the original optionee. In the event an optionee dies during his
employment by the Company or any of its subsidiaries, or during the three-month
period following the date of termination of such employment, his option shall
thereafter be exercisable, during the period specified in the option agreement,
by his executors or administrators to the full extent to which such option was
exercisable by the optionee at the time of his death during the periods set
forth in Section 10 or 11(d).

10.         EFFECT OF TERMINATION OF EMPLOYMENT OR OTHER RELATIONSHIP.

            Except as provided in Section 11(d) with respect to Incentive Stock
Options, and subject to the provisions of the Plan, an optionee may exercise an
option at any time within three (3) months following the termination of the
optionee's employment or other relationship with the Company or within one (1)
year if such termination was due to the death or disability of the optionee,
but, except in the case of the optionee's death, in no event later than the
expiration date of the Option. If the termination of the optionee's employment
is for cause or is otherwise attributable to a breach by the optionee of an
employment or confidentiality or non-disclosure agreement, the option shall
expire immediately upon such termination. The Board of Directors shall have the
power to determine what constitutes a termination for cause or a breach of an
employment or confidentiality or non-disclosure agreement, whether an optionee
has been terminated for cause or has breached such an agreement, and the date
upon which such termination for cause or breach occurs. Any such determinations
shall be final and conclusive and binding upon the optionee.

11.         INCENTIVE STOCK OPTIONS.

            Options granted under the Plan which are intended to be Incentive
Stock Options shall be subject to the following additional terms and conditions:

<PAGE>

            (a) EXPRESS DESIGNATION. All Incentive Stock Options granted under
the Plan shall, at the time of grant, be specifically designated as such in the
option agreement covering such Incentive Stock Options.

            (b) 10% STOCKHOLDER. If any employee to whom an Incentive Stock
Option is to be granted under the Plan is, at the time of the grant of such
option, the owner of stock possessing more than 10% of the total combined voting
power of all classes of stock of the Company (after taking into account the
attribution of stock ownership rules of Section 424(d) of the Code), then the
following special provisions shall be applicable to the Incentive Stock Option
granted to such individual:

               (i) The purchase price per share of the Common Stock subject to
            such Incentive Stock Option shall not be less than 110% of the Fair
            Market Value of one share of Common Stock at the time of grant; and

              (ii) the option exercise period shall not exceed five years from 
            the date of grant.

            (c) DOLLAR LIMITATION. For so long as the Code shall so provide,
options granted to any employee under the Plan (and any other incentive stock
option plans of the Company) which are intended to constitute Incentive Stock
Options shall not constitute Incentive Stock Options to the extent that such
options, in the aggregate, become exercisable for the first time in any one
calendar year for shares of Common Stock with an aggregate Fair Market Value, as
of the respective date or dates of grant, of more than $100,000.

            (d) TERMINATION OF EMPLOYMENT, DEATH OR DISABILITY. No Incentive
Stock Option may be exercised unless, at the time of such exercise, the optionee
is, and has been continuously since the date of grant of his or her option,
employed by the Company, except that:

               (i)  an Incentive Stock Option may be exercised within the period
            of three months after the date the optionee ceases to be an employee
            of the Company (or within such lesser period as may be specified in
            the applicable option agreement), PROVIDED, that the agreement with
            respect to such option may designate a longer exercise period and
            that the exercise after such three-month period shall be treated as
            the exercise of a non-statutory option under the Plan;

              (ii)  if the optionee dies while in the employ of the Company, or
            within three months after the optionee ceases to be such an
            employee, the Incentive Stock Option may be exercised by the person
            to whom it is transferred by will or the laws of descent and
            distribution within the period of one year after the date of death
            (or within such lesser period as may be specified in the applicable
            option agreement); and

<PAGE>

              (iii) if the optionee becomes disabled (within the meaning of
            Section 22(e)(3) of the Code or any successor provisions thereto)
            while in the employ of the Company, the Incentive Stock Option may
            be exercised within the period of one year after the date the
            optionee ceases to be such an employee because of such disability
            (or within such lesser period as may be specified in the applicable
            option agreement).

For all purposes of the Plan and any option granted hereunder, "employment"
shall be defined in accordance with the provisions of Section 1.421-7(h) of the
Income Tax Regulations (or any successor regulations). Notwithstanding the
foregoing provisions, no Incentive Stock Option may be exercised after its
expiration date.

12.         ADDITIONAL PROVISIONS.

            (a) ADDITIONAL OPTION PROVISIONS. The Board of Directors may, in its
sole discretion, include additional provisions in option agreements covering
options granted under the Plan, including without limitation restrictions on
transfer, repurchase rights, rights of first refusal, commitments to pay cash
bonuses, to make, arrange for or guaranty loans or to transfer other property to
optionees upon exercise of options, or such other provisions as shall be
determined by the Board of Directors; PROVIDED, that such additional provisions
shall not be inconsistent with any other term or condition of the Plan and such
additional provisions shall not cause any Incentive Stock Option granted under
the Plan to fail to qualify as an Incentive Stock Option within the meaning of
Section 422 of the Code.

            (b) ACCELERATION, EXTENSION, ETC. The Board of Directors may, in its
sole discretion, (i) accelerate the date or dates on which all or any particular
option or options granted under the Plan may be exercised or (ii) extend the
dates during which all, or any particular, option or options granted under the
Plan may be exercised; PROVIDED, HOWEVER, that no such extension shall be
permitted if it would cause the Plan to fail to comply with Section 422 of the
Code or with Rule 16b-3 (if applicable).

13.         GENERAL RESTRICTIONS.

            (a) INVESTMENT REPRESENTATIONS. The Company may require any person
to whom an option is granted, as a condition of exercising such option, to give
written assurances in substance and form satisfactory to the Company to the
effect that such person is acquiring the Common Stock subject to the option for
his or her own account for investment and not with any present intention of
selling or otherwise distributing the same, and to such other effects as the
Company deems necessary or appropriate in order to comply with federal and
applicable state securities laws, or with covenants or representations made by
the Company in connection with any public offering of its Common Stock.

            (b) COMPLIANCE WITH SECURITIES LAW. Each option shall be subject to
the requirement that if, at any time, counsel to the Company shall determine
that the listing, 

<PAGE>

registration or qualification of the shares subject to such option upon any
securities exchange or under any state or federal law, or the consent or
approval of any governmental or regulatory body, or that the disclosure of
non-public information or the satisfaction of any other condition is necessary
as a condition of, or in connection with the issuance or purchase of shares
thereunder, such option may not be exercised, in whole or in part, unless such
listing, registration, qualification, consent or approval, or satisfaction of
such condition shall have been effected or obtained on conditions acceptable to
the Board of Directors. Nothing herein shall be deemed to require the Company to
apply for or to obtain such listing, registration or qualification, or to
satisfy such condition.

14.         RIGHTS AS A STOCKHOLDER.

            The holder of an option shall have no rights as a stockholder with
respect to any shares covered by the option (including, without limitation, any
rights to receive dividends or non-cash distributions with respect to such
shares) until the date of issue of a stock certificate to him or her for such
shares. No adjustment shall be made for dividends or other rights for which the
record date is prior to the date such stock certificate is issued.

15.         ADJUSTMENT PROVISIONS FOR RECAPITALIZATIONS, REORGANIZATIONS AND 
            RELATED TRANSACTIONS.

            (a) RECAPITALIZATIONS AND RELATED TRANSACTIONS. If, through or as a
result of any recapitalization, reclassification, stock dividend, stock split,
reverse stock split or other similar transaction, (i) the outstanding shares of
Common Stock are increased, decreased or exchanged for a different number or
kind of shares or other securities of the Company, or (ii) additional shares or
new or different shares or other non-cash assets are distributed with respect to
such shares of Common Stock or other securities, an appropriate and
proportionate adjustment shall be made in (x) the maximum number and kind of
shares reserved for issuance under the Plan, (y) the number and kind of shares
or other securities subject to any then outstanding options under the Plan, and
(z) the price for each share subject to any then outstanding options under the
Plan, without changing the aggregate purchase price as to which such options
remain exercisable. Notwithstanding the foregoing, no adjustment shall be made
pursuant to this Section 15 if such adjustment (i) would cause the Plan to fail
to comply with Section 422 of the Code or with Rule 16b-3 or (ii) would be
considered as the adoption of a new plan requiring stockholder approval.

                  (b) REORGANIZATION, MERGER AND RELATED TRANSACTIONS. All
outstanding Options under the Plan shall become fully exercisable for a period
of sixty (60) days following the occurrence of any Trigger Event, whether or not
such Options are then exercisable under the provisions of the applicable
agreements relating thereto. For purposes of the Plan, a "Trigger Event" is any
one of the following events:

<PAGE>

                        (i) the date on which shares of Common Stock are first
            purchased pursuant to a tender offer or exchange offer (other than
            such an offer by the Company, any Subsidiary, any employee benefit
            plan of the Company or of any Subsidiary or any entity holding
            shares or other securities of the Company for or pursuant to the
            terms of such plan), whether or not such offer is approved or
            opposed by the Company and regardless of the number of shares
            purchased pursuant to such offer;

                        (ii) the date the Company acquires knowledge that any
            person or group deemed a person under Section 13(d)-3 of the
            Exchange Act (other than the Company, any Subsidiary, any employee
            benefit plan of the Company or of any Subsidiary or any entity
            holding shares of Common Stock or other securities of the Company
            for or pursuant to the terms of any such plan or any individual or
            entity or group or affiliate thereof which acquired its beneficial
            ownership interest prior to the date the Plan was adopted by the
            Board), in a transaction or series of transactions, has become the
            beneficial owner, directly or indirectly (with beneficial ownership
            determined as provided in Rule 13d-3, or any successor rule, under
            the Exchange Act), of securities of the Company entitling the person
            or group to 30% or more of all votes (without consideration of the
            rights of any class or stock to elect directors by a separate class
            vote) to which all stockholders of the Company would be entitled in
            the election of the Board of Directors were an election held on such
            date;

                        (iii) the date, during any period of two consecutive
            years, when individuals who at the beginning of such period
            constitute the Board of Directors of the Company cease for any
            reason to constitute at least a majority thereof, unless the
            election, or the nomination for election by the stockholders of the
            Company, of each new director was approved by a vote of at least
            two-thirds of the directors then still in office who were directors
            at the beginning of such period; and

                        (iv) the date of approval by the stockholders of the
            Company of an agreement (a "reorganization agreement") providing
            for:

                              (A) The merger or consolidation of the Company
                  with another corporation where the stockholders of the
                  Company, immediately prior to the merger or consolidation, do
                  not beneficially own, immediately after the merger or
                  consolidation, shares of the corporation issuing cash or
                  securities in the merger or consolidation entitling such
                  stockholders to 65% or more of all votes (without
                  consideration of the rights of any class of stock to elect
                  directors by a separate class vote) to which all stockholders
                  of such corporation would be entitled in the election of
                  directors or where the members of the Board of Directors of
                  the Company, immediately prior to the merger or consolidation,
                  do not, immediately 

<PAGE>

                  after the merger or consolidation, constitute a majority of 
                  the Board of Directors of the corporation issuing cash or 
                  securities in the merger or consolidation; or

                              (B) The sale or other disposition of all or
                  substantially all the assets of the Company.

            (c) BOARD AUTHORITY TO MAKE ADJUSTMENTS. Any adjustments under this
Section 15 will be made by the Board of Directors, whose determination as to
what adjustments, if any, will be made and the extent thereof will be final,
binding and conclusive. No fractional shares will be issued under the Plan on
account of any such adjustments.

16.         MERGER, CONSOLIDATION, ASSET SALE, LIQUIDATION, ETC.

            (a) GENERAL. In the event of a consolidation or merger or sale of
all or substantially all of the assets of the Company in which outstanding
shares of Common Stock are exchanged for securities, cash or other property of
any other corporation or business entity or in the event of a liquidation of the
Company, the Board of Directors of the Company, or the board of directors of any
corporation assuming the obligations of the Company, may, in its discretion,
take any one or more of the following actions, as to outstanding options: (i) in
the event of a merger under the terms of which holders of the Common Stock of
the Company will receive upon consummation thereof a cash payment for each share
surrendered in the merger (the "Merger Price"), make or provide for a cash
payment to the optionees equal to the difference between (A) the Merger Price
times the number of shares of Common Stock subject to such outstanding options
(to the extent then exercisable at prices not in excess of the Merger Price) and
(B) the aggregate exercise price of all such outstanding options in exchange for
the termination of such options, and (ii) in the event the provisions of Section
15 are not applicable, provide that all or any outstanding options shall become
exercisable in full immediately prior to such event and upon written notice to
the optionees, provide that all unexercised options will terminate immediately
prior to the consummation of such transaction unless exercised by the optionee
within a specified period following the date of such notice.

            (b) SUBSTITUTE OPTIONS. The Company may grant options under the Plan
in substitution for options held by employees of another corporation who become
employees of the Company, or a subsidiary of the Company, as the result of a
merger or consolidation of the employing corporation with the Company or a
subsidiary of the Company, or as a result of the acquisition by the Company, or
one of its subsidiaries, of property or stock of the employing corporation. The
Company may direct that substitute options be granted on such terms and
conditions as the Board of Directors considers appropriate in the circumstances.

17.         NO SPECIAL EMPLOYMENT RIGHTS.

            Nothing contained in the Plan or in any option shall confer upon any
optionee any right with respect to the continuation of his or her employment by
the Company or interfere in 

<PAGE>

any way with the right of the Company at any time to terminate such employment
or to increase or decrease the compensation of the optionee.

18.         OTHER EMPLOYEE BENEFITS.

            Except as to plans which by their terms include such amounts as
compensation, the amount of any compensation deemed to be received by an
employee as a result of the exercise of an option or the sale of shares received
upon such exercise will not constitute compensation with respect to which any
other employee benefits of such employee are determined, including, without
limitation, benefits under any bonus, pension, profit-sharing, life insurance or
salary continuation plan, except as otherwise specifically determined by the
Board of Directors.

19.         AMENDMENT OF THE PLAN.

            (a) The Board of Directors may at any time, and from time to time,
modify or amend the Plan in any respect; provided, however, that if at any time
the approval of the stockholders of the Company is required under Section 422 of
the Code or any successor provision with respect to Incentive Stock Options, or
under Rule 16b-3, the Board of Directors may not effect such modification or
amendment without such approval; and provided, further, that the provisions of
Section 3(c) hereof shall not be amended more than once every six months, other
than to comport with changes in the Code, the Employer Retirement Income
Security Act of 1974, as amended, or the rules thereunder.

            (b) The modification or amendment of the Plan shall not, without the
consent of an optionee, affect his or her rights under an option previously
granted to him or her. With the consent of the optionee affected, the Board of
Directors may amend outstanding option agreements in a manner not inconsistent
with the Plan. The Board of Directors shall have the right to amend or modify
(i) the terms and provisions of the Plan and of any outstanding Incentive Stock
Options granted under the Plan to the extent necessary to qualify any or all
such options for such favorable federal income tax treatment (including deferral
of taxation upon exercise) as may be afforded incentive stock options under
Section 422 of the Code and (ii) the terms and provisions of the Plan and of any
outstanding option to the extent necessary to ensure the qualification of the
Plan under Rule 16b-3.

20.         WITHHOLDING.

            (a) The Company shall have the right to deduct from payments of any
kind otherwise due to the optionee any federal, state or local taxes of any kind
required by law to be withheld with respect to any shares issued upon exercise
of options under the Plan. Subject to the prior approval of the Company, which
may be withheld by the Company in its sole discretion, the optionee may elect to
satisfy such obligations, in whole or in part, (i) by causing the Company to
withhold shares of Common Stock otherwise issuable pursuant to the exercise of
an option or (ii) by delivering to the Company shares of Common Stock already
owned by the 

<PAGE>

optionee. The shares so delivered or withheld shall have a Fair
Market Value equal to such withholding obligation as of the date that the amount
of tax to be withheld is to be determined. An optionee who has made an election
pursuant to this Section 20(a) may only satisfy his or her withholding
obligation with shares of Common Stock which are not subject to any repurchase,
forfeiture, unfulfilled vesting or other similar requirements.

            (b) The acceptance of shares of Common Stock upon exercise of an
Incentive Stock Option shall constitute an agreement by the optionee (i) to
notify the Company if any or all of such shares are disposed of by the optionee
within two years from the date the option was granted or within one year from
the date the shares were issued to the optionee pursuant to the exercise of the
option, and (ii) if required by law, to remit to the Company, at the time of and
in the case of any such disposition, an amount sufficient to satisfy the
Company's federal, state and local withholding tax obligations with respect to
such disposition, whether or not, as to both (i) and (ii), the optionee is in
the employ of the Company at the time of such disposition.

            (c) Notwithstanding the foregoing, in the case of a Reporting Person
whose options have been granted in accordance with the provisions of Section
3(b) herein, no election to use shares for the payment of withholding taxes
shall be effective unless made in compliance with any applicable requirements of
Rule 16b-3.

21.         CANCELLATION AND NEW GRANT OF OPTIONS, ETC.

            The Board of Directors shall have the authority to effect, at any
time and from time to time, with the consent of the affected optionees, (i) the
cancellation of any or all outstanding options under the Plan and the grant in
substitution therefor of new options under the Plan covering the same or
different numbers of shares of Common Stock and having an option exercise price
per share which may be lower or higher than the exercise price per share of the
cancelled options or (ii) the amendment of the terms of any and all outstanding
options under the Plan to provide an option exercise price per share which is
higher or lower than the then-current exercise price per share of such
outstanding options.

22.         EFFECTIVE DATE AND DURATION OF THE PLAN.

            (a) EFFECTIVE DATE. The Plan shall become effective when adopted by
the Board of Directors, but no Incentive Stock Option granted under the Plan
shall become exercisable unless and until the Plan shall have been approved by
the Company's stockholders. If such stockholder approval is not obtained within
twelve months after the date of the Board's adoption of the Plan, no options
previously granted under the Plan shall be deemed to be Incentive Stock Options
and no Incentive Stock Options shall be granted thereafter. Amendments to the
Plan not requiring stockholder approval shall become effective when adopted by
the Board of Directors; amendments requiring stockholder approval (as provided
in Section 19) shall become effective when adopted by the Board of Directors,
but no Incentive Stock Option granted after the date of such amendment shall
become exercisable (to the extent that such amendment to the Plan was required
to enable the Company to grant such Incentive 

<PAGE>

Stock Option to a particular optionee) unless and until such amendment shall
have been approved by the Company's stockholders. If such stockholder approval
is not obtained within twelve months of the Board's adoption of such amendment,
any Incentive Stock Options granted on or after the date of such amendment shall
terminate to the extent that such amendment to the Plan was required to enable
the Company to grant such option to a particular optionee. Subject to this
limitation, options may be granted under the Plan at any time after the
effective date and before the date fixed for termination of the Plan.

            (b) TERMINATION. Unless sooner terminated in accordance with Section
16, the Plan shall terminate upon the earlier of (i) the close of business on
the day next preceding the tenth anniversary of the date of its adoption by the
Board of Directors, or (ii) the date on which all shares available for issuance
under the Plan shall have been issued pursuant to the exercise or cancellation
of options granted under the Plan. If the date of termination is determined
under (i) above, then options outstanding on such date shall continue to have
force and effect in accordance with the provisions of the instruments evidencing
such options.

23.         PROVISION FOR FOREIGN PARTICIPANTS.

            The Board of Directors may, without amending the Plan, modify awards
or options granted to Participants who are foreign nationals or employed outside
the United States to recognize differences in laws, rules, regulations or
customs of such foreign jurisdictions with respect to tax, securities, currency,
employee benefit or other matters.

24.         GOVERNING LAW.

            The provisions of this Plan shall be governed and construed in
accordance with the laws of the State of Delaware without regard to the
principles of conflicts of laws.

            ADOPTED BY THE BOARD OF DIRECTORS ON JUNE 14, 1994 AND BY THE 
STOCKHOLDERS ON AUGUST 17 , 1994

            AMENDED BY THE BOARD OF DIRECTORS ON MAY 24,1995  AND BY THE 
STOCKHOLDERS ON AUGUST 25, 1995

            AMENDED BY THE BOARD OF DIRECTORS ON MAY 15, 1997 AND BY THE 
STOCKHOLDERS ON AUGUST 12, 1997


<PAGE>

                                 EXHIBIT 24(A)

<PAGE>

               INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS' CONSENT

      We consent to the incorporation by reference in this Registration
Statement of Bio-Logic Systems Corp. on Form S-8 of our report dated April 24,
1997, on our audits of the consolidated financial statements of Bio-Logic
Systems Corp. as of February 28, 1997 and February 29, 1996 and for the two
years in the period ended February 28, 1997, appearing in the Annual Report on
Form 10K-SB for the fiscal year ended February 28, 1997 (SEC File No. 0-12231)
of Bio-Logic Systems Corp. filed with the Securities and Exchange Commission
pursuant to the Securities Exchange Act of 1934.

                                          GRANT THORNTON LLP

Chicago, Illinois
September 16, 1997


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission